Jose Tinajero

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 10

Top Topics

Acute Myeloid Leukemia

Newly Diagnosed

Tyrosine Kinase

Top Venues

Leukemia & lymphoma

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Dat Ngo, Jose Tinajero, Jianying Zhang, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Vinod Pullarkat, Karamjeet S Sandhu, Brian J Ball, Hoda Pourhassan, Paul Koller
Concurrent versus sequential or no triazole anti-fungal therapy in patients undergoing 7 + 3 plus midostaurin induction for FLT-3 acute myelogenous leukemia. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Z Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela S Becker, Ryotaro Nakamura, Anthony S Stein, Guido Marcucci, Andrew S Artz, Paul Koller, Amandeep Salhotra
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. Leukemia & lymphoma 65 (7) (2024)
Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Z Pourhassan, Ahmed Aribi, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Karamjeet Sandhu, Vinod Pullarkat, Brian Ball, Paul B Koller
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leukemia & lymphoma (2024)
Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Z Pourhassan, Ahmed Aribi, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Karamjeet Sandhu, Vinod Pullarkat, Brian Ball, Paul B Koller
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leukemia & lymphoma 65 (3) (2024)
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Z Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela S Becker, Ryotaro Nakamura, Anthony S Stein, Guido Marcucci, Andrew S Artz, Paul Koller, Amandeep Salhotra
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. Leukemia & lymphoma (2024)
Dat Ngo, Jose Tinajero, Shanpeng Li, Joycelynne Palmer, Hoda Z Pourhassan, Ahmed Aribi, Ryotaro Nakamura, Anthony Stein, Guido Marcucci, Amandeep Salhotra, Karamjeet Sandhu, Vinod Pullarkat, Brian Ball, Paul B Koller
Treatment of relapsed or refractory FLT-3 acute myelogenous leukemia with a triplet regimen of hypomethylating agent, venetoclax, and gilteritinib. Leukemia & lymphoma 65 (3) (2024)
Purav Mehta, Dat Ngo, Jose Tinajero
Concomitant use of calcitonin gene-related peptide (CGRP) antagonists with azole antifungals in patients with hematological malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Dina Trang, Dat Ngo, Haris Ali, Jose Tinajero
Pacritinib and concurrent azole antifungal therapy is deliverable in patients with hematologic malignancies. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2024)
Jose Tinajero, Dat Ngo, Jianying Zhang, Ni-Chun Tsai, Ahmed Aribi, Ibrahim Aldoss, Vaibhav Agrawal, Shukaib Arslan, Idoroenyi Amanam, Hoda Z Pourhassan, Karamjeet Sandhu, Monzr Al-Malki, Vinod Pullarkat, Pamela S Becker, Ryotaro Nakamura, Anthony S Stein, Guido Marcucci, Andrew S Artz, Paul Koller, Amandeep Salhotra
High remission rates and transition to allogeneic transplant in older patients with newly diagnosed FLT-3 mutated acute myelogenous leukemia with midostaurin plus intensive chemotherapy. Leukemia & lymphoma 65 (7) (2024)
Mina Nikanjam, Jose Tinajero, Donald A Barkauskas, Razelle Kurzrock
BRAF V600E/V600K Mutations versus Nonstandard Alterations: Prognostic Implications and Therapeutic Outcomes. Molecular cancer therapeutics 20 (6) (2021)